IP Library Granted Patent US 8,740,888
Granted Patent B2
US 8,740,888 · App. 12/016,558 · Granted Jun 3, 2014

Computer control for bio-mechanical alteration of the cornea

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,740,888
App. No.
12/016,558
Granted
Jun 3, 2014
Kind
B2
Abstract

A system and method for altering the shape of a lamina of transparent material (e.g. the cornea of an eye), as it is being subjected to a transverse pressure differential, requires a computer controlled laser unit. In accordance with specified input parameters, the computer directs the laser unit to perform LIOB over predetermined surfaces within the lamina. This weakens the material for a desired reshaping of the lamina in response to the pressure differential. With respect to a perpendicular axis that is defined by the lamina, surfaces parallel to the axis (e.g. cylindrical surfaces) are separated from each other by about two hundred microns. For surfaces perpendicular to the axis, the separation is about ten microns. In each instance, the cuts that result from LIOB are only about two microns thick.

Claims (39)

1. A method for controlling a laser beam to perform an intrastromal ophthalmic surgical procedure to alter the shape of a transparent lamina in an eye, the method comprising the steps of:

electronically connecting a computer with a laser unit;

identifying an axis substantially perpendicular to the lamina, wherein the axis establishes a reference datum for movement of the laser beam;

creating a predetermined computer program for directing the laser unit to make a first surface enclosed within the lamina in accordance with requirements of the surgical procedure and a second surface unconnected with the first surface, wherein the surfaces are substantially parallel, and are defined relative to the axis to weaken the lamina;

determining cutting parameter coordinates for each of the surfaces;

entering the cutting parameter coordinates into the computer, wherein the cutting parameter coordinates are defined relative to the axis;

generating a laser beam with the laser unit;

focusing the laser beam to a focal spot in the lamina; and

moving the focal spot in accordance with the cutting parameters, to perform Laser Induced Optical Breakdown (LIOB) over each defined surface inside the lamina, and wherein said first surface and said second surface each have a thickness of approximately two microns to weaken the lamina and alter the shape of the lamina in response to forces imposed on the eye parallel to the axis.

2. A method as recited in claim 1 further comprising the step of inputting cutting parameters to the computer for the first and second surfaces, wherein the parameters define portions of each surface for LIOB.

3. A method as recited in claim 2 wherein the cutting parameters include a location for a distal end of the first surface (Z distal ) n wherein “n” identifies the surface, a location for a proximal end of the first surface (Z proximal ) n , a radius “r n ” measured from the axis, and an azimuthal angle θ measured around the axis from a base line.

4. A method as recited in claim 3 wherein the azimuthal angle θ is constant, and the radius “r n ” is varied through a range of approximately three millimeters to create a radial cut.

5. A method as recited in claim 3 wherein each defined surface is a cylindrical curved surface and each cylindrical curved surface is centered on the axis.

6. A method as recited in claim 5 wherein the radius “r n ” is constant to create a circular cylindrical curved surface.

7. A method as recited in claim 1 further comprising the step of selectively moving the focal spot in accordance with the predetermined computer program for the LIOB of material on the first and second surfaces comprising annular shaped layers in the lamina, wherein each layer is centered on the axis, and the LIOB of the material results in a layer having a thickness of approximately two microns, and further wherein adjacent layers are approximately ten microns distant from each other.

8. A method as recited in claim 7 further comprising the step of inputting layer parameters to the computer, wherein the layer parameters define portions of the layers for LIOB.

9. A method as recited in claim 8 wherein the layer parameters include an axial location for each layer Z m wherein “m” identifies the layer, an inner diameter (d i ) m , an outer diameter (d o ) m , and an azimuthal angle θ measured around the axis.

10. A computer program product for use with a computer for controlling a laser beam to perform an intrastromal ophthalmic surgical procedure on tissue in the cornea of an eye, wherein the computer program product comprises program sections for respectively:

electronically connecting the computer with a laser unit;

identifying a visual axis for the eye, wherein the axis establishes a reference datum for movement of the laser beam during the surgical procedure;

programming the laser unit to perform Laser Induced Optical Breakdown (LIOB) over a first surface enclosed within the cornea in accordance with requirements of the surgical procedure and a second surface unconnected with the first surface, wherein each surface is programmed to weaken the cornea, and each is defined relative to the axis;

determining cutting parameter coordinates for each the first and second surfaces;

entering the cutting parameter coordinates into the computer, wherein the cutting parameter coordinates are defined relative to the axis;

generating a laser beam with the laser unit;

focusing the laser beam to a focal spot in the cornea; and

moving the focal spot in accordance with the predetermined computer program in the computer to perform Laser Induced Optical Breakdown (LIOB) over the first and second surfaces inside the cornea, wherein the first and second surfaces are substantially parallel and wherein each of the first and second surfaces has a thickness of approximately 2 microns to weaken the cornea over the surface and alter the shape of the cornea in response to forces imposed on the eye parallel to the axis.

11. A computer program product as recited in claim 10 further comprising a program section for inputting cutting parameters to the computer for the first and second surface, wherein the cutting parameters define portions of each of the first and second surfaces for LIOB and include a location for a distal end of each surface (Z distal ) n wherein “n” identifies the particular surface, a location for a proximal end of each surface (Z proximal ) n , a radius “r n ” measured from the axis, and an azimuthal angle θ measured around the axis from a base line.

12. A computer program product as recited in claim 11 wherein the azimuthal angle θ is constant, and the radius (r c ) n is varied through a range of approximately three millimeters to create a radial cut.

13. A computer program product as recited in claim 11 wherein each of the first and second surfaces is a cylindrical curved surface and each cylindrical curved surface is centered on the axis.

14. A computer program product as recited in claim 11 wherein the program section for moving the focal point further comprises selectively moving the focal spot over the first and second surfaces in accordance with the predetermined computer program for the LIOB of material on a plurality of annular shaped layers in the cornea, wherein each layer is centered on the axis, and the LIOB of the material results in a layer having a thickness of approximately two microns, and further wherein the adjacent layers are approximately ten microns distant from each other.

15. A computer program product as recited in claim 14 further comprising a program section for inputting layer parameters to the computer, wherein the layer parameters define portions of the layers for LIOB and include an axial location for each layer Z m wherein “m” identifies the particular layer, an inner diameter (d i ) m , an outer diameter (d o ) m , and an azimuthal angle θ measured around the axis.

16. A system for controlling a laser beam during an ophthalmic surgical procedure to alter the shape of a transparent lamina, the system comprising:

a laser unit for generating and focusing a laser beam to a focal spot in the lamina;

a predetermined computer program for use with an identified axis substantially perpendicular to the lamina, wherein the axis establishes a reference datum for movement of the laser beam during the surgical procedure, and for directing the laser unit to make a first surface and a second surface unconnected, and substantially parallel, with the first surface, the first and second surfaces enclosed within the lamina by moving the focal spot of the laser beam in accordance with cutting parameter coordinates relative to the axis, wherein the first and second surfaces are selected in accordance with requirements of the surgical procedure to weaken the lamina; and

a computer connected to the laser unit for moving the focal spot in accordance with the predetermined computer program, and relative to the axis, to perform Laser Induced Optical Breakdown (LIOB) over each of the first and second surfaces inside the lamina, wherein each of the first and second surfaces has been defined relative to the axis by coordinates for the predetermined program and wherein each of the first and second surfaces has a thickness of approximately two microns to weaken the lamina over the surface and alter the shape of the lamina in response to forces imposed on the lamina parallel to the axis.

17. A system as recited in claim 16 wherein the predetermined computer program operates with cutting parameters for the first and second surfaces and the parameters for each surface of the first and second surfaces include a location for a distal end of each surface (Z distal ) n wherein “n” identifies the particular surface, a location for a proximal end of each surface (Z proximal ) n , a radius “r n ” measured from the axis, and an azimuthal angle θ measured around the axis.

18. A system as recited in claim 16 wherein each of the first and second surfaces is cylindrical and is centered on the axis.

19. A system as recited in claim 16 wherein the predetermined computer program moves the focal spot in accordance with the predetermined computer program for the LIOB of material on a plurality of annular shaped layers in the lamina, wherein each layer is centered on the axis, and the LIOB of the material results in a layer having a thickness of less than approximately two microns, and further wherein the adjacent layers are approximately ten microns distant from each other.

20. A system as recited in claim 19 wherein the predetermined computer program operates with layer parameters including an axial location for each layer Z m wherein “m” identifies the layer, an inner diameter (d i ) m , an outer diameter (d o ) m , and an azimuthal angle θ measured around the axis.

Assignments (12)
RELEASE OF SECURITY INTEREST Recorded Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC; DOW PHARMACEUTICAL SCIENCES, INC.; ECR PHARMACEUTICALS CO., INC.; LABORATOIRE CHAUVIN S.A.S.; MEDICIS PHARMACEUTICAL CORPORATION; ONPHARMA INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; SALIX PHARMACEUTICALS, LTD.; SALIX PHARMACEUTICALS, INC.; SANTARUS, INC.; SOLTA MEDICAL, INC.; SYNERGETICS USA, INC.; TECHNOLAS PERFECT VISION GMBH; VALEANT CANADA LP; VALEANT PHARMACEUTICALS INTERNATIONAL; VALEANT PHARMACEUTICALS INTERNATIONAL, INC.; VALEANT PHARMACEUTICALS NORTH AMERICA LLC; WIRRA IP PTY LIMITED; VALEANT PHARMA POLAND SP. Z O.O.; VALEANT PHARMACEUTICALS LUXEMBOURG S.A R.L.; VALEANT PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 073637/0001 →
RELEASE OF SECURITY INTEREST Recorded Nov 20, 2025
From: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
To: BAUSCH HEALTH IRELAND LIMITED; BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH, CANADA INC.; TECHNOLAS PERFECT VISION GMBH; VALEANT PHARMACEUTICALS LUXEMBOURG S.A R.L.; VALEANT PHARMA POLAND SPOLKA Z ORGANICZONA ODPOWIEDZIALNOSCIA; VALEANT SP. Z.O.O.
Reel/Frame 073637/0222 →
OMNIBUS PATENT SECURITY RELEASE AGREEMENT (REEL/FRAME 045444/0634) Recorded Nov 2, 2022
From: THE BANK OF NEW YORK MELLON
To: BAUSCH & LOMB INCORPORATED; LABORATOIRE CHAUVIN S.A.S.; TECHNOLAS PERFECT VISION GMBH; THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES
Reel/Frame 061872/0295 →
OMNIBUS PATENT SECURITY RELEASE AGREEMENT (REEL/FRAME 057821/0800) Recorded Nov 2, 2022
From: THE BANK OF NEW YORK MELLON
To: TECHNOLAS PERFECT VISION GMBH; BAUSCH + LOMB IRELAND LIMITED
Reel/Frame 061884/0514 →
RELEASE OF SECURITY INTEREST IN SPECIFIED PATENTS (REEL/FRAME 036400/0711) Recorded Oct 26, 2022
From: BARCLAYS BANK PLC
To: BAUSCH & LOMB INCORPORATED; TECHNOLAS PERFECT VISION GMBH
Reel/Frame 061775/0826 →
RELEASE OF SECURITY INTEREST IN SPECIFIED PATENTS (REEL/FRAME 045444/0299) Recorded Oct 26, 2022
From: BARCLAYS BANK PLC
To: BAUSCH & LOMB INCORPORATED; TECHNOLAS PERFECT VISION GMBH; THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES; PF CONSUMER HEALTHCARE 1 LLC; LABORATOIRE CHAUVIN S.A.S.
Reel/Frame 061779/0001 →
SECURITY INTEREST Recorded Oct 5, 2021
From: BAUSCH & LOMB IRELAND LIMITED; BAUSCH HEALTH COMPANIES INC.; DR. GERHARD MANN CHEM.-PHARM. FABRIK GMBH; TECHNOLAS PERFECT VISION GMBH
To: THE BANK OF NEW YORK MELLON, AS NOTES COLLATERAL AGENT
Reel/Frame 057821/0800 →
INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Jul 3, 2019
From: BAUSCH HEALTH IRELAND LIMITED; BAUSCH HEALTH COMPANIES INC.; BAUSCH HEALTH, CANADA INC.; TECHNOLAS PERFECT VISION GMBH; VALEANT PHARMACEUTICALS LUXEMBOURG S.À R.L.; VALEANT PHARMA POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA; VALEANT SP. Z O. O.
To: THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT
Reel/Frame 049672/0652 →
SECURITY INTEREST Recorded Feb 26, 2018
From: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC; DOW PHARMACEUTICAL SCIENCES, INC.; ECR PHARMACEUTICALS CO., INC.; LABORATOIRE CHAUVIN S.A.S.; MEDICIS PHARMACEUTICAL CORPORATION; ONPHARMA INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; SALIX PHARMACEUTICALS, LTD.; SALIX PHARMACEUTICALS, INC.; SANTARUS, INC.; SOLTA MEDICAL, INC.; SYNERGETICS USA, INC.; TECHNOLAS PERFECT VISION GMBH; VALEANT CANADA LP; VALEANT PHARMACEUTICALS INTERNATIONAL; VALEANT PHARMACEUTICALS INTERNATIONAL, INC.; VALEANT PHARMACEUTICALS NORTH AMERICA LLC; WIRRA IP PTY LIMITED; VALEANT PHARMA POLAND SP. Z O.O.; VALEANT PHARMACEUTICALS LUXEMBOURG S.A R.L.; VALEANT PHARMACEUTICALS IRELAND LIMITED
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 045444/0299 →
SECURITY INTEREST Recorded Feb 26, 2018
From: ATON PHARMA, INC.; BAUSCH & LOMB INCORPORATED; BAUSCH & LOMB PHARMA HOLDINGS CORP.; COMMONWEALTH LABORATORIES, LLC; DOW PHARMACEUTICAL SCIENCES, INC.; ECR PHARMACEUTICALS CO., INC.; LABORATOIRE CHAUVIN S.A.S.; MEDICIS PHARMACEUTICAL CORPORATION; ONPHARMA INC.; ORAPHARMA, INC.; PRECISION DERMATOLOGY, INC.; SALIX PHARMACEUTICALS, LTD.; SALIX PHARMACEUTICALS, INC.; SANTARUS, INC.; SOLTA MEDICAL, INC.; SYNERGETICS USA, INC.; TECHNOLAS PERFECT VISION GMBH; VALEANT CANADA LP; VALEANT PHARMACEUTICALS INTERNATIONAL; VALEANT PHARMACEUTICALS INTERNATIONAL, INC.; VALEANT PHARMACEUTICALS NORTH AMERICA LLC; WIRRA IP PTY LIMITED; VALEANT PHARMA POLAND SP. Z O.O.; VALEANT PHARMACEUTICALS LUXEMBOURG S.A R.L.; VALEANT PHARMACEUTICALS IRELAND LIMITED
To: THE BANK OF NEW YORK MELLON, AS COLLATERAL AGENT
Reel/Frame 045444/0634 →
SECURITY INTEREST Recorded Jul 19, 2017
From: TECHNOLAS PERFECT VISION GMBH
To: THE BANK OF NEW YORK MELLON
Reel/Frame 043251/0910 →
SECURITY AGREEMENT Recorded Aug 20, 2015
From: TECHNOLAS PERFECT VISION GMBH; DR. GERHARD MANN CHEM-PHARM. FABRIK GMBH
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 036400/0711 →